Macrophage migration inhibitory factor (MIF): genetic evidence for participation in early onset and early stage rheumatoid arthritis

Por Llamas-Covarrubias, MA, Valle, Y, Bucala, R, Navarro-Hernández, RE, Palafox-Sánchez, CA, Padilla-Gutiérrez, JR, Parra-Rojas, I, Bernard-Medina, AG, Reyes-Castillo, Z, Muñoz-Valle, JF
Publicado em 2013

Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associ...

Por Reyes-Castillo, Z, Palafox-Sánchez, C A, Parra-Rojas, I, Martínez-Bonilla, G E, del Toro-Arreola, S, Ramírez-Dueñas, M G, Ocampo-Bermudes, G, Muñoz-Valle, José F
Publicado no Clin Exp Immunol (2015)

A potential inflammatory role of IL-31 in psoriatic arthritis: A correlation with Th17 cytokine profile

Por Bautista-Herrera, LA, De la Cruz-Mosso, U, Román-Fernández, IV, Parra-Rojas, I, Soñanez-Organis, JG, Hernández-Bello, J, Morales-Zambrano, RA, Villanueva-Quintero, GD, Muñoz-Valle, JF
Publicado no Int J Immunopathol Pharmacol (2020)

Macrophage migration inhibitory factor: Association of -794 CATT(5-8) and -173 G>C polymorphisms with TNF-α in systemic lupus erythematosus

Por De la Cruz-Mosso, U, Bucala, R, Palafox-Sánchez, CA, Parra-Rojas, I, Padilla- Gutiérrez, JR, Pereira-Suárez, AL, Rangel-Villalobos, H, Vázquez-Villamar, M, Angel-Chávez, LI, Muñoz-Valle, JF
Publicado em 2014

Association of CD28 IVS3 +17T/C Polymorphism with Soluble CD28 in Rheumatoid Arthritis

Por Ledezma-Lozano, I. Y., Padilla-Martínez, J. J., Leyva-Torres, S. D., Parra-Rojas, I., Ramírez-Dueñas, M. G., Pereira-Suárez, Ana Laura, Rangel-Villalobos, H., Ruiz-Quezada, S. L., Sánchez-Hernández, P. E., Muñoz-Valle, J. F.
Publicado em 2011